BenzingaOctober 12, 2026 at 9:37 AM NY15 Days Ago
BMO Capital Maintains Market Perform on Amgen, Lowers Price Target to $415
BMO Capital analyst Evan David Seigerman maintains Amgen (NASDAQ:AMGN) with a Market Perform and lowers the price target from $450 to $415.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
